LIST OF TABLES
TABLE 01.ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 02.ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY FOR COLORECTAL CANCER, 2018-2026 ($MILLION)
TABLE 03.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY PCR-BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 04.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY NGS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 05.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FLOW CYTOMETRY BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 06.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 07.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 08.COLORECTAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY OTHERS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 09.ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES , BY COUNTRY, 2018-2026 ($MILLION)
TABLE 10.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY PCR-BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 11.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY NGS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 12.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FLOW CYTOMETRY BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 13.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 14.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 15.HEMATOLOGICAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY OTHERS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 16.ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR BREAST CANCER , 2018-2026 ($MILLION)
TABLE 17.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY PCR-BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 18.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY NGS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 19.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FLOW CYTOMETRY BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 20.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 21.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 22.BREAST ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY OTHERS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 23.ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR LUNG CANCER , 2018-2026 ($MILLION)
TABLE 24.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY PCR-BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 25.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY NGS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 26.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FLOW CYTOMETRY BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 27.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 28.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 29.LUNG ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY OTHERS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 30.ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR OTHERS , BY COUNTRY , 2018-2026 ($MILLION)
TABLE 31.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY PCR-BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 32.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY NGS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 33.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FLOW CYTOMETRY BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 34.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY FISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 35.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY CISH BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 36.OTHERS ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY OTHERS BASED TECHNOLOGY, 2018-2026 ($MILLION)
TABLE 37.ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER 2018-2026 ($MILLION)
TABLE 38.ASIA PACIFIC ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY , 2018-2026 ($MILLION)
TABLE 39.ASIA PACIFIC ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES , BY COUNTRY , 2018-2026 ($MILLION)
TABLE 40.ASIA PACIFIC ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET FOR OTHERS , BY COUNTRY , 2018-2026 ($MILLION)
TABLE 41.ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2018-2026 ($MILLION)
TABLE 42.AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 43.AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 44.VIETNAM ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 45.VIETNAM ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 46.THAILAND ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 47.THAILAND ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 48.PHILLIPINES ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 49.PHILLIPINES ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 50.REST OF ASIA PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018-2026 ($MILLION)
TABLE 52.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 53.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 54.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 55.BIOMEREUX SA: COMPANY SNAPSHOT
TABLE 56.BIOMEREUX SA: PRODUCT PORTFOLIO
TABLE 57.BIOMEREUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58.QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 59.QIAGEN N.V.: OPERATING SEGMENT
TABLE 60.QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 61.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 62.F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 63.F. HOFFMAN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 64.F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 65.F. HOFFMAN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 66.SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 67.SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 68.SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 69.DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 70.DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 71.DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 72.DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 73.DIASORIN SPA: COMPANY SNAPSHOT
TABLE 74.DIASORIN SPA: PRODUCT PORTFOLIO
TABLE 75.DIASORIN SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 76.ILLUMINA INC.: COMPANY SNAPSHOT
TABLE 77.ILLUMINA INC.: OPERATING SEGMENTS
TABLE 78.ILLUMINA INC.: PRODUCT PORTFOLIO
TABLE 79.ILLUMINA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80.AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 81.AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 82.AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
TABLE 83.AGILENT TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84.SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 85.SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 86.SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 87.SYSMEX CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.TOP INVESTMENT POCKETS
FIGURE 02.TOP PLAYER POSITIONING, 2018
FIGURE 03.LOW BARGAINAING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINAING POWER OF SUPPLIERS
FIGURE 05.LOW THREAT OF SUBSITUTION
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.HIGHLY COMPETITIVE RIVALRY
FIGURE 08.MARKET DYNAMICS
FIGURE 09.MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018
FIGURE 10.MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018
FIGURE 11.MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018
FIGURE 12.MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018
FIGURE 13.MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018
FIGURE 14.ABBOTT LABORATORIES: NET SALES, 2016-2018 ($MILLION)
FIGURE 15.ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 16.ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 17.BIOMEREUX SA.: NET SALES, 2016-2018 ($MILLION)
FIGURE 18.BIOMEREUX SA: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 19.QIAGEN N.V.: NET SALES, 2016-2018 ($MILLION)
FIGURE 20.QIAGEN N.V.: REVENUE SHARE, BY PRODUCT CATEGORY, 2018 (%)
FIGURE 21.QIAGEN N.V.: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 22.F. HOFFMAN-LA ROCHE LTD: NET SALES, 2017-2019 ($MILLION)
FIGURE 23.F. HOFFMAN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 24.SIEMENS HEALTHINEERS: NET SALES, 2017-2019 ($MILLION)131
FIGURE 25.SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 26.SIEMENS HEALTHINEERS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 27.DANAHER CORPORATION: NET SALES, 2016-2018 ($MILLION)135
FIGURE 28.DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 29.DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 30.DIASORIN SPA: NET SALES, 2016-2018 ($MILLION)
FIGURE 31.DIASORIN SPA: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 32.ILLUMINA INC: NET SALES, 2017-2019 ($MILLION)
FIGURE 33.ILLUMINA INC: REVENUE SHARE, BY PRODUCTS, 2019 (%)
FIGURE 34.ILLUMINA INC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 35.AGILENT TECHNOLOGIES INC: NET SALES, 2017-2019 ($MILLION)
FIGURE 36.AGILENT TECHNOLOGIES INC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.AGILENT TECHNOLOGIES INC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.SYSMEX CORPORATION: NET SALES, 2017-2019 ($MILLION)
FIGURE 39.SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2019 (%)
